Project Details
| Short title | APOLLO |
|---|---|
| Status | Finished |
| Effective start/end date | 16/05/19 → 15/05/24 |
A phase 1/2 open label, multi-center dose escalation and expansion study of combination immunotherapy CBT-501 (anti-PD-1) or nivolumab with CBT-101 (c-Met inhibitor) in locally advanced or metastatic hepatocellular carcinoma and renal cell carcinoma
- Sabanathan, Dhanusha (Associate Investigator)
- Chapman, Nicola (Other)
- Butala, Radhika (Other)
- Gurney, Howard (Primary Chief Investigator)
Project: Other